Peripartum Cardiomyopathy Registry Biomarker sub-protocol

• Conditions: Peripartum cardiomyopathy; pregnancy related heart failure; 10028593; 10010273

• Registration Number: NL-OMON43678
• Lead Sponsor: European Society of Cardiology

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 23 April 2024

Recruitment & Eligibility

• Status: Pending
• Sex: Not specified
• Target Recruitment: 20

Inclusion Criteria

Patients with peripartum cardiomyopathy
1. peripartum stage
2. Signs and/or symptoms of heart failure
3. Ejection fraction <45%

Exclusion Criteria

Other cause of heart failure

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The primary objective of this registry is to describe the epidemiology and<br /><br>prognosis of outpatients and inpatients with PPCM and the diagnostic and<br /><br>therapeutic processes.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>The registry will serve to identify parameters that serve as diagnostic and<br /><br>prognostic markers* these may be useful for identification and risk<br /><br>stratification. Biomarkers such as NT-proBNP, Soluble ST2, Galectin -3,<br /><br>metalloproteinases, C-reactive protein and other biomarkers that may arise to<br /><br>be potentially important during the execution of this study, will be evaluated.</p><br>